154 related articles for article (PubMed ID: 7940725)
21. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Reynaert H; De Coninck A; Neven AM; Van Camp B; Schots R
Bone Marrow Transplant; 1992 Aug; 10(2):185-7. PubMed ID: 1388082
[TBL] [Abstract][Full Text] [Related]
22. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Schneider EM; Dörries K
Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
[No Abstract] [Full Text] [Related]
23. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
Miyamura K; Barrett AJ; Kodera Y; Saito H
Bone Marrow Transplant; 1994 Aug; 14(2):201-9. PubMed ID: 7994233
[TBL] [Abstract][Full Text] [Related]
24. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
25. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
[TBL] [Abstract][Full Text] [Related]
26. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
Baker KS; Loberiza FR; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ
J Clin Oncol; 2005 Oct; 23(28):7032-42. PubMed ID: 16145067
[TBL] [Abstract][Full Text] [Related]
27. Separation of graft-vs.-host disease and graft-vs.-leukemia effect against chronic myelogenous leukemia.
Champlin R
Exp Hematol; 1995 Oct; 23(11):1148-51. PubMed ID: 7556522
[No Abstract] [Full Text] [Related]
28. A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
Henslee PJ; Byers VS; Jennings CD; Marciniak E; Thompson JS; Macdonald JS; Romond EH; Messino MJ; Scannon PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3004-7. PubMed ID: 2650413
[No Abstract] [Full Text] [Related]
29. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
31. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
32. Late pulmonary impairment following allogeneic bone marrow transplantation.
Beinert T; Düll T; Wolf K; Holler E; Vogelmeier C; Behr J; Kolb H
Eur J Med Res; 1996 Apr; 1(7):343-8. PubMed ID: 9364037
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
34. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
35. Diagnosing graft versus host disease.
O'Rourke ME; High K
Clin J Oncol Nurs; 2000; 4(1):47-8. PubMed ID: 10865586
[No Abstract] [Full Text] [Related]
36. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
[TBL] [Abstract][Full Text] [Related]
37. [Bone marrow transplantation in chronic myeloid leukemia].
Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
[TBL] [Abstract][Full Text] [Related]
38. Importance of bone marrow cell dose in bone marrow transplantation.
Paulin T
Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
[TBL] [Abstract][Full Text] [Related]
39. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
40. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
